• In swap for faster UK launches, pharma caps sales growth at 2% fiercepharma
    November 27, 2018
    How much are pharma companies willing to pay in exchange for a faster trip to market in the U.K.? As it turns out, a cap of 2% on total branded-drug sales growth should do. And that’s a deal the industry is billing as a big savings for the government next
PharmaSources Customer Service